Laura Raniere Borges dos Anjos

Laura Raniere Borges dos Anjos

Auto-generated profile, based on publicly available information

Laura Raniere Borges dos Anjos

Doutora em Biotecnologia e Biodiversidade pela Universidade Federal de Goiás (UFG), Goiânia, Goiás, Brasil; acadêmico de Medicina da Universidad Interamericana; Consultor Científico pelo Instituto de Educação Estatística e Científica, Trindade, Goiás, Brasil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2022 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
KBKellen Christina Malheiros Borges
Kellen Christina Malheiros Borges
ACAdeliane Castro da Costa
Adeliane Castro da Costa
LBLília Cristina de Souza Barbosa
Lília Cristina de Souza Barbosa
KRKaio Mota Ribeiro
Kaio Mota Ribeiro
LALaura Raniere Borges dos Anjos
Laura Raniere Borges dos Anjos
Ana Paula Junqueira-KipnisAna Paula Junqueira-Kipnis
Ana Paula Junqueira-Kipnis
Evidence from multiple scientific studies suggests that the Bacillus Calmette–Guérin (BCG) vaccine, widely used worldwide as a preventive measure against tuberculosis, also offers crossprotection against other pathogens. This review aimed to gather data from research that studied the mechanisms involved in the immunological protection induced by the BCG vaccine, which may be important in the control of viral infections, such as COVID-19. Through a literature review, we compiled information about the different BCG strains used worldwide, as well as the responses and protection elicited by them. We commented on the mechanisms of immune response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and we discussed the possibility of cross-protection of different BCG strains on the control of COVID-19. Due to the immunomodulatory properties of BCG, some BCG strains were able to induce an effective cellular immune response and, through epigenetic modifications, activate cells of the innate immune system, such as monocytes, macrophages and natural killer cells, which are crucial for the control of viral infections. Although several vaccines have already been developed and used in an attempt to control the COVID-19 pandemic, some BCG vaccine strains may help stimulate the basal defences against these pathogens and can be used as additional defences in this and future pandemics.

9 August 2023 in World Journal of Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
LALaura Raniere Borges dos Anjos
Laura Raniere Borges dos Anjos
VCVinícius Alexandre Fiaia Costa
Vinícius Alexandre Fiaia Costa
BNBruno Neves
Bruno Neves
Ana Paula Junqueira-KipnisAna Paula Junqueira-Kipnis
Ana Paula Junqueira-Kipnis
Ana Paula Junqueira-KipnisAna Paula Junqueira-Kipnis
Ana Paula Junqueira-Kipnis

16 March 2026 in Revista Goiana de Medicina
Verified
Journal Article
Open access
PDF file
LALeandro Prado Assunção
Leandro Prado Assunção
BNBenedito Rodrigues da Silva Neto
Benedito Rodrigues da Silva Neto
AMAndré Luís Elias Moreira
André Luís Elias Moreira
LMLarissa Oliveira Rosa Marques
Larissa Oliveira Rosa Marques
IOIgor Mendes Moreira de Oliveira
Igor Mendes Moreira de Oliveira
LALaura Raniere Borges dos Anjos
Laura Raniere Borges dos Anjos
Introduction: Although the introduction of vaccination against whooping cough significantly reduced its incidence, recent years have shown a resurgence, emphasizing the importance of temporal and regional analyses to understand disease dynamics and support epidemiological surveillance. Objective: To develop a time series model to forecast whooping cough cases in Brazil for the years 2026 and 2027. Material and Methods: This ecological time series study analyzed whooping cough notifications in Brazil from 2007 to 2024 using publicly available data from SINAN/Tabnet/DataSUS. Data were organized into monthly and annual series following GATHER guidelines. Series characteristics were evaluated using Dickey-Fuller, Mann-Kendall, Kruskal- Wallis, and Box-Pierce tests. ARIMA and SARIMA models were applied to forecast cases for 2026 and 2027 with 95% confidence intervals. Analyses were performed using R (v4.3.2) and Excel, according to established protocols previously. Results: Between 2007 and 2024, 42354 cases were recorded of whooping cough. It was observed that the South and Southeast were the regions most affected by whooping cough during this period. The results indicated that, although the ARIMA and SARIMA models identified for each region exhibited relatively stable profiles of stationarity, trend, and seasonality, the analysis based on the model adjusted with the complete dataset up to 2024 allowed for more robust and reliable forecasts. The forecast indicates an increase in whooping cough cases in the Southeast region from May to October 2026 and from July to December 2027. In the South region, a smaller but prolonged increase is observed from January and March 2026 and from August 2026 to December 2027, suggesting significant seasonal variations. Conclusion: Whooping cough is reemerging in Brazil with cyclical trends and unequal geographic distribution. Forecasts suggest increasing cases in the coming years, especially in the Southeast and South, reinforcing the need for continuous surveillance, targeted vaccination campaigns, and proactive public health interventions.

12 September 2026 in SN Comprehensive Clinical Medicine
Verified
Journal Article
Open access
PDF file
DAdos Anjos
dos Anjos
LBLaura Raniere Borges
Laura Raniere Borges
LALeandro Do Prado Assunção
Leandro Do Prado Assunção
KSKamilla de Faria Santos
Kamilla de Faria Santos
RSRodrigo da Silva Santos
Rodrigo da Silva Santos
ARANGELA ADAMSKI DA SILVA REIS
ANGELA ADAMSKI DA SILVA REIS
Purpose: Diabetic nephropathy (DN) is a major microvascular complication of type 2 diabetes, where genetic predisposition significantly influences susceptibility. Genetic variants that exacerbate oxidative stress and endothelial injury can disrupt glomerular microvascular integrity and permeability. Together, these molecular alterations may contribute to albuminuria and progressive deterioration of renal function, as reflected by declining estimated glomerular filtration rate (eGFR). Methods: This pilot case-control study investigated the association of two genetic variants, MTHFR rs1801133 and VEGF-A rs28357093, with DN in 345 individuals from Central Brazil. Genotyping was performed using PCR-RFLP. Clinical and genetic data were analyzed using logistic regression under different inheritance models and five supervised machine learning (SML) algorithms (CART, RF, KNN, SVM, and LR). Model performance was assessed using accuracy, precision, sensitivity, specificity, ROC curve analysis, bootstrap resampling, and a sensitivity analysis excluding fasting blood glucose, serum creatinine, and eGFR. Results: The MTHFR (rs1801133) and VEGF-A (rs28357093) variants were associated with DN risk ( p = 0.05 and p = 0.02, respectively). ML analyses demonstrated high predictive performance, with RF and CART achieving the highest discriminative ability among the evaluated algorithms. KNN and LR showed high sensitivity, reaching recall values of up to 1.00. eGFR and glycated hemoglobin emerged as the most influential predictors, whereas the genetic variants provided complementary predictive information. These findings highlight the potential of ML approaches for integrating clinical and genetic data in DN risk prediction. Conclusion: ML models exhibited satisfactory predictive performance driven mainly by clinical parameters. The observed results support the potential utility of integrating genetic data into predictive workflows while highlighting the importance of larger cohorts for refining precision risk stratification in DN.